November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium ...
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non ...
November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human trial ...
November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 11, 2011 — Maquet Cardiovascular announced U.S. Food and Drug Administration (FDA) 510(k) clearance and CE mark ...
November 10, 2011 – GE Healthcare will feature several new products and solutions at the Cardiovascular Research ...
November 9, 2011 — InfraReDx Inc. announced the launch of its TVC Imaging System, an enhanced version of the LipiScan ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 9, 2011 — Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute drug-eluting ...
November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 9, 2011 — Volcano Corp. announced results from the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluatio ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
November 8, 2011 — Biosensors International Group Ltd. announced final results of the AXXESS PLUS trial, which ...
November 8, 2011 – Boston Scientific reports clinical endpoint data from its PLATINUM Long Lesion trial, demonstrating ...
November 7, 2011 — The American College of Cardiology Foundation (ACCF), American Heart Association (AHA), and Society ...
November 14, 2011